Article Text

PDF
Anti-proteasome autoantibodies contribute to anti-nuclear antibody patterns on human larynx carcinoma cells
  1. E Feist1,*,
  2. M Brychcy1,*,
  3. G Hausdorf1,
  4. B Hoyer2,
  5. K Egerer1,
  6. T Dörner3,
  7. U Kuckelkorn4,
  8. G-R Burmester1
  1. 1Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany
  2. 2Deutsches Rheumaforschungszentrum, Berlin, Germany
  3. 3Institute of Transfusion Medicine, Charité-Universitätsmedizin Berlin, Germany
  4. 4Institute of Biochemistry, Charité-Universitätsmedizin Berlin, Germany
  1. Correspondence to:
    Dr Eugen Feist
    Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Charitéplatz 1, Berlin D-10117, Germany; eugen.feist{at}charite.de

Abstract

Background: Autoantibodies to the 20S proteasome represent an unspecific but common serological phenomenon in patients with systemic autoimmune diseases. Interestingly, a high prevalence of these antibodies have been observed in patients with connective tissue diseases, where anti-nuclear antibodies (ANAs) serve as an important diagnostic screening test.

Objective: To disclose interference of anti-proteasome antibodies with known ANA patterns.

Methods: Anti-proteasome antibodies were isolated for comprehensive immunofluorescence analyses. The immunofluorescence pattern of human anti-proteasome antibodies was compared with a panel of monoclonal and polyclonal reference antibodies, and colocalisation was analysed using confocal microscopy.

Results: Anti-proteasome antibodies clearly contributed to the ANA patterns of their respective serum samples from patients with different rheumatic disorders. In addition to the nuclear pattern, proteasomal staining was also detectable in the cytoplasm, at the endoplasmic reticulum and perinuclear regions showing features overlapping with other known autoantibodies such as those to mitochondria. The specificity of anti-proteasome antibodies was proved by competition experiments and by colocalisation with monoclonal reference antibodies in confocal microscopy.

Conclusion: In ANA diagnostics, interference of anti-proteasome antibodies will have to be taken into account, especially in the differentiation of anti-cytoplasmatic autoantibodies.

  • ANA, anti-nuclear antibody
  • FITC, fluorescein isothiocyanate
  • IIF, indirect immunofluorescence
  • PA28, proteasome activator
  • PAGE, polyacrylamide gel electrophoresis
  • TAP, transporter associated with antigen processing

Statistics from Altmetric.com

Footnotes

  • * These authors contributed equally to this work.

  • Published Online First 30 June 2006

  • Funding: This study was supported by the Kompetenznetz-Rheuma C2.3 of the German Ministry of Education and Science, and by grants from Deutsche Forschungsgemeinschaft (SFB421/B13 and DFG Ku1261).

  • Competing interests: None declared.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.